Finding Description
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 2. Resident #31 was admitted to the facility on [DATE] with diagnoses which included diabetes mellitus, urinary retention and chronic obstructive pulmonary disease.
Review of the current plan of care related to bladder incontinence and urinary tract infections (UTI) revealed to monitor Resident #31 for signs and symptoms (s/s) including pain, burning, blood tinged urine, cloudiness, no urine output, deepening of urine color, increased temperature, urinary frequency, foul smelling urine, chills, altered mental status, change in behaviors and/or eating patterns. Check and change every two hours and as needed for incontinence. Wash, rinse and dry perineum after each incontinence episode, encourage adequate fluids and give antibiotic therapy as ordered. Notify the physician with any signs or symptoms (s/s) of a UTI.
Review of the physician progress note dated 05/18/21 revealed there were no concerns with Resident #31 continue to encourage fluids.
Review of the nurse notes dated 05/17/21, 05/18/21 and 05/19/21 revealed there was no evidence Resident #31 had any s/s of a UTI.
Review of the 05/19/21 urinalysis/culture and sensitivity (UA/C&S) test was submitted to the laboratory for testing. Further review of the physician order revealed an antibiotic (ATB) was started for 10 days.
Review of the nurses notes dated 05/19/21 revealed the physician was notified Resident #31 did not meet the criteria for the ATB stewardship program.
Review of the suspected UTI SBAR revealed Resident #31 did not meet the criteria to initiate ATB. The assessment was not signed or dated by any staff including the physician but did indicate an ATB was initiated.
Review of the UA/C&S results dated 05/21/21 revealed the results were received from the facility to show Resident #31 had escherichia coli in her urine.
Review of the medication administration record (MAR) revealed Resident #31 received the ATB as ordered from 05/19/21 through 05/29/21.
Review of the nurses notes dated 06/01/21 revealed Resident #31 had foul smelling urine but no other s/s and a UA/C&S was collected on 06/02/21.
Review of the nurses notes was dated 06/04/21 revealed to start Resident #31 on an intramuscular ATB due to the UA/C&S reported 06/04/21 stated Resident #31 had proteus mirabilis and providencia stuartii in her urine.
Review of the suspected UTI SBAR, dated 06/04/21, revealed Resident #31 did not meet the criteria to start an ATB therapy. There were no signatures on the assessment.
Review of the physician progress note dated 06/08/21 revealed there was no evidence Resident #31 had any recent UTIs.
Further review of the MAR revealed Resident #31 continued the course of ATB until it was finished on 06/14/21.
Review of the bladder assessment, dated 06/16/21, revealed Resident #31 was incontinent of urine.
Review of the nurses notes 06/14/21 through 06/25/21 revealed Resident #31 had no s/s of a UTI but on 06/20/21 a follow up UA/C&S was collected.
Review of the results of the UA/C&S reported 06/23/21 revealed Resident #31 had enercoccoccus faecalis in her urine and was started on an ATB.
Review of the suspected UTI SBAR, dated 06/24/21, revealed Resident #31 did not meet the criteria for starting ATB therapy. The assessment was not signed.
Further review of the nurses notes dated 06/26/21 revealed Resident #31 had a change in mental status and no other s/s.
Review of the MAR revealed Resident #31 started a course of ATB in the evening of 06/24/21 and continued to course until 07/01/21. The nurses notes dated 06/27/21, 06/28/21 and 07/01/21 indicated Resident #31 had foul smelling urine but no other s/s.
Review of the annual minimum data set (MDS) 3.0 dated 07/01/12 revealed Resident #31 was cognitively intact but needed assistance of staff for toileting.
Review of the physician progress note dated 07/06/21 revealed there was no evidence Resident #31 had recent UTIs.
Review of the nurses notes dated 07/07/21 revealed a follow up UA/C&S was obtained. Further review of the results reported on 07/09/21 revealed Resident #31 had pseudomonas airuginosa in her urine and the physician ordered an ATB despite not having any s/s.
Review of the suspected UTI SBAR, dated 07/09/21, revealed Resident #31 did not meet the criteria for initiating ATB therapy. The assessment was not signed.
Further review of the MAR revealed the ATB therapy was given as ordered from 07/09/21 through 07/19/21.
On 07/19/21 at 12:20 P.M., interview with Resident #31 denied any concerns with incontinence or UTIs.
On 07/20/21 at 8:17 A.M., 10:32 A.M., 11:23 A.M. and 12:35 P.M., Resident #31 was observed in bed. At 1:17 P.M., the resident was receiving incontinence care by State Tested Nurse Aide (STNA) #56 and #66.
On 07/20/21 at 1:36 P.M., interview with STNA #56 verified Resident #31 frequently refused to be taken to the toilet and frequently refused incontinence care. This was the first time all day she would allow them to do incontinence care. When the resident was taken to the toilet she performed her own pericare but when incontinent the staff provided pericare.
On 07/20/21 at 1:45 P.M., interview with STNA #66 verified Resident #31 had been refusing to be toileted and changed all day because she liked to stay in bed and not be bothered. When the resident was taken to the toilet she performed her own pericare but when incontinent the staff provided pericare.
On 07/21/21 at 9:40 A.M., Resident #31 was observed sleeping in bed.
On 07/21/21 at 10:58 A.M., interview with the Director of Nursing (DON) and LPN #62, who was assisting in the infection prevention role, verified the medical director (MD) #80 was the physician at the facility and he saw all the residents. The DON stated MD #80 thought Resident #31 may have a dropped bladder but the resident refused to go see a urologist. LPN #62 verified she initiated all above suspected UTI SBAR assessments and they may not have been completed timely and verified there were no signatures by any staff nor the physician. LPN #62 also verified the SBARs showed Resident #31 did not meet the criteria for initiated ATB therapy and when she informed the physician he would still continue the ATB therapy. The DON stated the nurse who received the results of the UA/C&S should inform the physician of the results with the results of the suspected UTI SBAR but there was no evidence this was being done. The DON stated it was the physician's decision when to use the ATB and had not done any education and/or training with the physician related to the ATB stewardship program. The DON verified the ATB stewardship policy and procedures were not being followed in an attempt to reduce the use of ATBs.
On 07/21/21 at 11:27 A.M. and 2:00 P.M., Resident #31 was observed sleeping in bed.
On 07/21/21 at 3:08 P.M., interview with Pharmacist (RPH) #80 revealed he was not included in the ATB stewardship program nor did he receive any of the UA/C&S results. RPH #80 stated the facility had a high rate of ATB usage and was informed of this but there had not been any discussions in an attempt to try and reduce the amount of ATB use.
On 07/21/21 at 4:10 P.M., Resident #31 was receiving incontinence care.
On 07/22/21 at 3:12 P.M., phone interview with MD #80 verified he attended the quality assurance meetings as well as addressed any concerns the day they arise and does not wait until a meeting. When asked about ATB stewardship program he stated there was still some debate on that but verified he was not involved in the program. The physician stated he tried not to use an ATB unless they were needed. He verified Resident #31 was on four different ATBs that did not meet the criteria for use since May 2021 but his progress notes did not reflect the resident had any UTIs.
Review of the ATB stewardship program policy, dated 11/11/17, revealed the program would improve resident safety and potentially impact rates of antimicrobial resistance. The act of using ATBs appropriately by using ATBs only when truly needed and by using the correct ATB for each infection. Stewardship or protecting the effectiveness of ATB, which is the most important tool available to treat life threatening bacterial infections. ATB resistance occurs when the bacteria adapt so drugs used to treat infections are less effective or do not work at all. The facility would work closely with the Center for Disease Control (CDC) recommendations and implement their core elements consisting of the infection preventionist (IP) having resources, the Medical Director being responsible for the program outcomes and the pharmacist working with staff to improve (reduce) ATB use. The facility would work together to identify recommended actions as an ATB time out 48-72 hours after the initial ATB had been started. This would include working closely with the physician and the pharmacist after the culture results become available to see if the ATB is the right choice, dose and route. And if an ATB should be given and if so for how long the ATB should be given. The facility would monitor at a minimum: if started in the facility, was the suspected UTI SBAR form used, which ATB was prescribed, cultures that were performed including results, was ATB appropriate or were there resistance patterns. The IP would report at a minimum quarterly, at the quality assurance meeting, to the physician, nurses and relevant staff the findings on ATB use and resistance and the on-going process. Education would be completed and performed to staff on an on-going and case-by-case bases on audits of the suspected UTI SBAR use, ATB initiation and result findings. The facility would educate staff on the Stop-and-Watch program to help identify changes in the resident conditions. Staff would fill out the Stop-and-Watch form, located at both nurses stations, when a change in condition or something out of the normal was recognized. The facility would follow the policy titled minimum criteria for common infections.
Review of the minimum criteria for common infections, dated 11/22/17, revealed it was aimed at reducing the unnecessary prescribing for the three infections where ATB were most frequently prescribed including UTIs. The resident suspected of having an infection would be assessed and a suspected UTI SBAR form would be completed. For UTIs without an indwelling catheter, the resident should meet criteria of one of the three situations: acute dysuria alone OR fever of 100 degrees Fahrenheit AND at least one of the following new or worsening conditions: urgency, frequency, suprapubic pain, gross hematuria, costovertebral angle tenderness, urinary incontinence OR no fever, then two or more of the following: urgency, frequency, suprapubic pain, gross hematuria or urinary incontinence. Also, urine cultures should not be used to identify UTIs in the absence of symptoms. Smelly or cloudy urine is not a symptom of a UTI. Urine cultures should be used to identify the most appropriate ATB use if needed.
Based on medical record review, policy review, review of infection control tracking logs, and interview, the facility failed to ensure residents who received antibiotic orders were reviewed for appropriateness of use in a timely manner to permit communication with the physician regarding those residents who did not meet criteria of infections. The facility also failed to involve the pharmacist in the antibiotic stewardship program after multiple residents were treated with antibiotics without criteria for infections being met. This affected one (Resident #31) of two residents reviewed for urinary tract infections and had the potential to affect all 41 other residents currently residing in the facility. The facility census was 42.
Findings include:
1. Review of the facility's Antibiotic Stewardship Program policy (effective 11/11/17) revealed the pharmacist was to work with staff to improve antibiotic use. The facility would monitor antibiotics started in the facility if the SBAR (SBAR is an acronym for Situation, Background, Assessment, Recommendation; a technique that can be used to facilitate prompt and appropriate communication.) was form was used and if the antibiotic use was appropriate. The policy indicated the facility was to follow a policy titled Minimum Criteria for Common Infections.
Review of the facility's policy, Minimum Criteria for Common Infections (effective 11/22/17), indicated the purpose of the policy was to reduce unnecessary use of antibiotics. If a resident did not meet criteria the nurse could ask the physician for supporting treatment. The SBAR form was to be used on an as needed basis any time an infection was suspected regardless of the type of infection. The policy indicated minimum criteria were necessary for initiating an antibiotic.
Review of the May 2021 Infection control tracking log revealed the following residents were treated for infections but evaluation on the SBAR revealed the residents did not meet the criteria for infections:
Resident #200 for a urinary tract infection (UTI)
Resident #205 for pneumonia
Resident #210 for UTI
Resident #215 for pneumonia
Resident #31 for UTI
Resident #43 for UTI
Review of the June 2021 Infection control tracking log revealed the following residents were treated for infections but evaluation on the SBAR revealed the residents did not meet the criteria for infections:
Resident #31 for UTI with onset dates of 06/05/21 and 06/24/21
Review of the July 2021 Infection control tracking log revealed the following residents were treated for infections but only one resident (Resident #31) had an evaluation on the SBAR and criteria for infection was not met:
Resident #43 for UTI
Resident #36 for wound infection
Resident #31 for UTI
Resident #44 for skin infection
Resident #6 for UTI
Resident #1 for pneumonia
Resident #12 for pneumonia
On 07/21/21 at 3:13 P.M., Pharmacist #80 stated he had not been involved in the antibiotic stewardship program, indicating he had not been asked to discuss the use of antibiotics for residents who did not meet criteria for infections with the physician.
On 07/22/21 at 1:45 P.M., Licensed Practical Nurse (LPN) #62 stated she was responsible for notifying the physician if residents with antibiotic orders did not meet criteria for infections. The physician did not provide rationale for continuing antibiotics without the criteria being met.
On 07/22/21 at 2:30 P.M., Administrator #43 stated he was aware of the physician prescribing antibiotics without criteria being met. Administrator #43 stated the facility discussed antibiotic use and infections every month during Quality Assurance meetings but refused to provide a topic list of areas discussed.
On 07/22/21 at 4:40 P.M., LPN #62 stated the facility had not evaluated antibiotics ordered in July 2021 to determine if criteria for infections was met. LPN #62 agreed the facility would not be able to address if an ordered antibiotic did not meet criteria for an infection if staff did not evaluate if criteria was met in timely manner.